289 related articles for article (PubMed ID: 31705784)
1. [
Bak-Fredslund KP; Keiding S; Villadsen GE; Kramer S; Schlander S; Sørensen M
Liver Int; 2020 Feb; 40(2):447-455. PubMed ID: 31705784
[TBL] [Abstract][Full Text] [Related]
2. The potential use of 2-[¹⁸F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma.
Sørensen M; Frisch K; Bender D; Keiding S
Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1723-31. PubMed ID: 21553087
[TBL] [Abstract][Full Text] [Related]
3. 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT of hepatocellular carcinoma is not improved by co-administration of galactose.
Bak-Fredslund KP; Munk OL; Keiding S; Sørensen M
Nucl Med Biol; 2016 Sep; 43(9):577-580. PubMed ID: 27434609
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.
Refaat R; Basha MAA; Hassan MS; Hussein RS; El Sammak AA; El Sammak DAEA; Radwan MHS; Awad NM; Saad El-Din SA; Elkholy E; Ibrahim DRD; Saleh SA; Montasser IF; Said H
Eur Radiol; 2018 Dec; 28(12):5356-5367. PubMed ID: 29948070
[TBL] [Abstract][Full Text] [Related]
5. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
[TBL] [Abstract][Full Text] [Related]
6. Extrahepatic metastases of hepatocellular carcinoma on
Sarma M; Padma S; Pavithran P; Somasundaram VH; Sundaram PS
J Egypt Natl Canc Inst; 2021 Nov; 33(1):36. PubMed ID: 34825288
[TBL] [Abstract][Full Text] [Related]
7. Addition of [
John BV; Aubuchon S; Dahman B; Konjeti VR; Heuman D; Hubert J; Thomas S; Deng Y; Solomon C; Sundaram LT; Love E; Singal AG; Tatum JL
Liver Transpl; 2020 Jun; 26(6):774-784. PubMed ID: 32128966
[TBL] [Abstract][Full Text] [Related]
8. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Ho CL; Chen S; Yeung DW; Cheng TK
J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
[TBL] [Abstract][Full Text] [Related]
9.
Na SJ; Oh JK; Hyun SH; Lee JW; Hong IK; Song BI; Kim TS; Eo JS; Lee SW; Yoo IR; Chung YA; Yun M
J Nucl Med; 2017 May; 58(5):730-736. PubMed ID: 27789714
[TBL] [Abstract][Full Text] [Related]
10. Optimal 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT protocol for detection of hepatocellular carcinoma.
Horsager J; Bak-Fredslund K; Larsen LP; Villadsen GE; Bogsrud TV; Sørensen M
EJNMMI Res; 2016 Dec; 6(1):56. PubMed ID: 27341819
[TBL] [Abstract][Full Text] [Related]
11. [Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
Chen Z; Liang H; Zhang X; Wang X; Chen W; Shi X; Yi C; Rao L
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1615-9. PubMed ID: 23174588
[TBL] [Abstract][Full Text] [Related]
12. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-induced modulation of glucose transporter expression impacts
Xia H; Chen J; Gao H; Kong SN; Deivasigamani A; Shi M; Xie T; Hui KM
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):787-797. PubMed ID: 31832727
[TBL] [Abstract][Full Text] [Related]
14. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB
J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075
[TBL] [Abstract][Full Text] [Related]
15. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
[TBL] [Abstract][Full Text] [Related]
16. Efficiency of whole-body 18F-FDG PET CT in detecting the cause of rising serum AFP level in post-therapeutic follow-up for HCC patients.
Ali SA; Amin DH; Abdelkhalek YI
Jpn J Radiol; 2020 May; 38(5):472-479. PubMed ID: 32078123
[TBL] [Abstract][Full Text] [Related]
17. The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver disease.
Mikkelsen KS; Sørensen M; Frisch K; Villadsen GE; Bibby BM; Keiding S
J Nucl Med; 2014 Apr; 55(4):590-4. PubMed ID: 24591487
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of pre-and postoperative 18F-FDG PET/CT in patients undergoing liver transplantation for hepatocellular carcinoma.
Wang XL; Li H; Wang QS; Zhang XL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1087-91, 1095. PubMed ID: 16939890
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value for extrahepatic metastases of hepatocellular carcinoma in positron emission tomography/computed tomography scan.
Lee JE; Jang JY; Jeong SW; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Jin SY; Choi DL
World J Gastroenterol; 2012 Jun; 18(23):2979-87. PubMed ID: 22736922
[TBL] [Abstract][Full Text] [Related]
20. Comparison of PET imaging of activated fibroblasts and
Shi X; Xing H; Yang X; Li F; Yao S; Congwei J; Zhao H; Hacker M; Huo L; Li X
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1593-1603. PubMed ID: 33097975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
